CTP354
CTP354, also known as C-21191, a novel deuterated subtype-selective GABA(A) modulator. CTP may be potentially useful for treatment of neuropathic pain, spasticity and anxiety disorders. GABAA receptors are found in the nervous system and, when activated, reduce the transmission of certain nerve signals. Several classes of widely used drugs target GABAA receptors, including benzodiazepines, but do not have the receptor subtype selectivity of CTP-354.
Supplier | Ace Therapeutics |
---|---|
Product # | SMD161 |
CAS # | 1213669-91-0 |
Pricing | Customizable size, Inquiry |
Synonym | CTP354; CTP-354; CTP 354; C-21191; C 21191; C21191. |
Product Category | Lab-use Small Molecule Drugs |
Chemical Formula | C19H10D9F2N7O |
Exact Mass | 408.21841 |
Molecular Weight | 408.46072 |
Elemental Analysis | C, 55.87; H, 6.91; F, 9.30; N, 24.00; O, 3.92 |
IUPAC/Chemical Name | 3-(2,5-difluorophenyl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)-7-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)-[1,2,4]triazolo[4,3-b]pyridazine |
InChi Key | BQDUNOMMYOKHEP-GQALSZNTSA-N |
InChi Code | InChI=1S/C19H19F2N7O/c1-19(2,3)13-8-15-24-25-17(12-7-11(20)5-6-14(12)21)28(15)26-18(13)29-9-16-22-10-23-27(16)4/h5-8,10H,9H2,1-4H3/i1D3,2D3,3D3 |
SMILES Code | CN1N=CN=C1COC2=NN3C(C=C2C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=NN=C3C4=CC(F)=CC=C4F |
Appearance | Solid powder |
Purity | >98% (or refer to the Certificate of Analysis) |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO, not in water |
Shelf Life | >2 years if stored properly |
Drug Formulation | This drug may be formulated in DMSO |
Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
HS Tariff Code | 2934.99.9001 |
Availability | 2 Weeks |